Bristol-Myers Squibb to Present Opdivo Stabilized Patient-reported Outcomes in Patients With Previously Treated Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck in Pivotal Phase 3 CheckMate -141 Study at ESMO 2016
Charles Gross